Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hatch Proposes Tougher Penalties For Steroid-Spiked Supplements

This article was originally published in The Tan Sheet

Executive Summary

Industry trade groups back the Designer Anabolic Steroid Control Act of 2012, which would create stiffer penalties for firms that taint supplements with anabolic steroids and strengthen DEA’s ability to identify and remove products with steroid analogues.

You may also be interested in...



Steroid-Spiked Supplement Bill Lingers In Roiling Senate Climate

Time for passing the legislation is running short with Congress leaving to focus on campaigns and with multiple issues already claiming priority for congressional action. The mid-term elections also could diminish the bill’s chances, as well as change control of the Senate and create large turnover in the House.

Steroid-Spiked Supplement Bill Lingers In Roiling Senate Climate

Time for passing the legislation is running short with Congress leaving to focus on campaigns and with multiple issues already claiming priority for congressional action. The mid-term elections also could diminish the bill’s chances, as well as change control of the Senate and create large turnover in the House.

FDA, Trade Groups Team Up To Bolster Enforcement On Tainted Supplements

FDA threatens to take "swift and strong" enforcement action without warning, including filing criminal charges, against manufacturers, suppliers and distributors of tainted supplements, according to a letter sent to industry Dec. 15.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel